Promoviendo la esperanza: AFTD asiste a AAIC 2024.

Text: Advancing Hope - AFTD Attends AAIC 2024. Background: AFTD, FTD Disorders Registry and Alzheimer' Association logos. AFTD's Shana Dodge presents at AAIC 2024.

Debra Niehoff, Kim Jenny, and Shana Dodge from AFTD and Sweatha Reddy from the FTD Disorders Registry attended the Alzheimer’s Association International Conference (AAIC), which took place in Philadelphia starting July 26, 2024. AAIC welcomed more than 9,000 attendees from 93 countries and included sessions and posters on the science of Alzheimer’s Disease and related…

Leer más

El director de marketing de Aviado Bio habla sobre el ensayo clínico ASPIRE-FTD con Neurology Live

In a recent interview with Neurology Live, Aviado Bio chief medical officer David Cooper, MD, discussed the company’s Phase 1/2 ASPIRE-FTD trial. Dr. Cooper shared how the company’s AVB-101 gene therapy worked, and he outlined what criteria the study would need to meet to be successful. The ASPIRE-FTD trial is focused on treating a specific…

Leer más

Estudio investiga las tasas de incidencia de DFT y otras demencias de aparición temprana en Italia

Text: Study Investigates Incidence Rates of FTD and Other Young-Onset Dementias in Italy Background: Two scientists looking over results on a PC screen

A study published in the journal Diagnosis, Assessment & Disease Monitoring investigates the incidence of neurodegenerative young-onset dementias (YODs) like FTD in the Brescia province of Italy. As highlighted by the authors of the study, the focus of most services for persons affected by dementia are tailored to the needs of older people and are…

Leer más